RELATED CONTENT
NEWS
- Gilenya and Tasigna drive new product growth at Novartis
- Alliance Boots explores collaboration with Nanjing Pharma to bolster Chinese presence
- 2011 US submission for Genentech/Curis' vismodegib in basal cell carcinoma
- Japan to improve blood products independence through merger of plasma producers

